標(biāo)題: Titlebook: Drug Repurposing for Emerging Infectious Diseases and Cancer; Ranbir Chander Sobti,Sunil K. Lal,Ramesh K. Goyal Book 2023 The Editor(s) (i [打印本頁(yè)] 作者: Lipase 時(shí)間: 2025-3-21 18:03
書(shū)目名稱(chēng)Drug Repurposing for Emerging Infectious Diseases and Cancer影響因子(影響力)
書(shū)目名稱(chēng)Drug Repurposing for Emerging Infectious Diseases and Cancer影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Drug Repurposing for Emerging Infectious Diseases and Cancer網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Drug Repurposing for Emerging Infectious Diseases and Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Drug Repurposing for Emerging Infectious Diseases and Cancer被引頻次
書(shū)目名稱(chēng)Drug Repurposing for Emerging Infectious Diseases and Cancer被引頻次學(xué)科排名
書(shū)目名稱(chēng)Drug Repurposing for Emerging Infectious Diseases and Cancer年度引用
書(shū)目名稱(chēng)Drug Repurposing for Emerging Infectious Diseases and Cancer年度引用學(xué)科排名
書(shū)目名稱(chēng)Drug Repurposing for Emerging Infectious Diseases and Cancer讀者反饋
書(shū)目名稱(chēng)Drug Repurposing for Emerging Infectious Diseases and Cancer讀者反饋學(xué)科排名
作者: 不成比例 時(shí)間: 2025-3-21 20:24 作者: 倒轉(zhuǎn) 時(shí)間: 2025-3-22 01:27
Ranbir Chander Sobti,Sunil K. Lal,Ramesh K. GoyalHighlight different drug repositioning strategies against infectious disease and cancer.Summarizes computational approaches that are used in drug repositioning studies.Presents experimental models to 作者: genesis 時(shí)間: 2025-3-22 05:51 作者: ADAGE 時(shí)間: 2025-3-22 11:49
Benedikt Korf,Timothy Raeymaekerss such as drug repurposing are required to develop therapeutics to treat both common and rare disorders. Drug repurposing is a potential approach in drug discovery for identifying new therapeutic applications for existing medications that are distinct from the original medical indication. Identifica作者: finite 時(shí)間: 2025-3-22 16:16
Benedikt Korf,Timothy Raeymaekersby shifting the focus from one target-one drug model to a multi-target approach. Polypharmacology uses comprehensive detailed knowledge about the composition of the drug, pathogenesis course of its mode of action, drug toxicology, pharmacodynamics, pharmacokinetics, and their side effects. Drug phar作者: finite 時(shí)間: 2025-3-22 18:41
Markus Virgil Hoehne,Dereje Feyissarates big datasets that are mined to identify previously unknown drug–event combinations, and, as an extension, may help in identifying new indications for old drugs. The therapeutic potential of a drug using pharmacovigilance-based drug repurposing can be assessed in one of the four ways—serendipit作者: cutlery 時(shí)間: 2025-3-22 22:41
Jennifer Feather,Catherine E. Thomas level of expression in the cerebellar cortex and hippocampus. According to cellular protein–protein interactor analysis, it appears to play a role in transcription control. Protein–protein interactions play fundamental roles in physiological roles such as cell proliferation, gene regulation, cell s作者: gusher 時(shí)間: 2025-3-23 01:32 作者: ALIBI 時(shí)間: 2025-3-23 07:38
Jennifer Feather,Catherine E. Thomasecome important due to new findings about their diverse pharmacological actions. Here in this chapter, we described about the repurposed use of flavonoids to treat different types of lung cancers such as small-cell lung cancer and non–small-cell lung cancer. The flavonoids covered in this chapter ar作者: MERIT 時(shí)間: 2025-3-23 11:20 作者: conflate 時(shí)間: 2025-3-23 16:25 作者: corn732 時(shí)間: 2025-3-23 19:29
https://doi.org/10.1057/9781137349927ssential components of UPS (Ubiquitinating enzymes-E1, E2, E3, deubiquitinases, and proteasome machinery) is complex and multifaceted, and their dysregulation has been implicated in several diseases including cancer. Increasing number of studies has established UPS as a cancer therapeutic target. In作者: 滔滔不絕地說(shuō) 時(shí)間: 2025-3-23 22:27 作者: DOTE 時(shí)間: 2025-3-24 02:29 作者: 擁護(hù)者 時(shí)間: 2025-3-24 09:03 作者: 孵卵器 時(shí)間: 2025-3-24 12:23 作者: 松緊帶 時(shí)間: 2025-3-24 16:17 作者: 構(gòu)成 時(shí)間: 2025-3-24 20:25 作者: bifurcate 時(shí)間: 2025-3-25 03:12
Kyuil Chung,Soyoung Kim,Hyun Song Shinovery and development of new antimicrobial agents. Traditional drug discovery and development involves several stages for the discovery of a new drug and to obtain marketing approval. Drug repurposing also referred to as drug repositioning has been influential in identifying new therapeutic uses for作者: 結(jié)果 時(shí)間: 2025-3-25 07:16 作者: 不確定 時(shí)間: 2025-3-25 09:04
Violence and Visibility in Modern Historybuted to this global health crisis is by no means the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 is characterized by an episode of immune fluctuations, followed by hyperactivation of inflammatory responses, known as the cytokine storm. The rapid progression of the COVID-1作者: GEN 時(shí)間: 2025-3-25 14:50
Veronica Alfano,Andrew Stauffercacy of the repurposing approach. By definition, drug repurposing is the process of identification of new therapeutic use of an existing drug or drug candidate that has already passed the safety, toxicity and pharmacology tests for human use. Although drug repurposing approach involves a significant作者: 除草劑 時(shí)間: 2025-3-25 16:14 作者: Semblance 時(shí)間: 2025-3-25 22:09
Benedikt Korf,Timothy Raeymaekersapproaches are already developed to increase the speed and ease of the repurposing process. With the advancement of technologies such as proteomics, genomics, transcriptomics, metabolomics and the availability of massive databases resources such as drug omics data, disease omics data and so on, ther作者: Prophylaxis 時(shí)間: 2025-3-26 00:36 作者: LATER 時(shí)間: 2025-3-26 04:25 作者: BATE 時(shí)間: 2025-3-26 11:09 作者: 青石板 時(shí)間: 2025-3-26 16:06
https://doi.org/10.1057/9781137349927nd associated investigations of drug repurposing over the previous decade. Some of these medications successfully regulate at least one characteristic of cancer, whereas the others have a broad anticancer activity by regulating several targets through different signaling pathways, which is often bro作者: formula 時(shí)間: 2025-3-26 17:51 作者: JEER 時(shí)間: 2025-3-26 21:12
Why Macroprudential Policy? Brief Overviewh results in improved outcomes therapeutically. We have described the immunomodulatory mechanism associated with the cancer treatment involving the cytokines, adjuvants, checkpoints, and agonists and hypothesized restricting tumour development by interrupting the tumour cell cycle and promoting apop作者: Foreshadow 時(shí)間: 2025-3-27 02:52
Kyuil Chung,Soyoung Kim,Hyun Song Shinthis field, could lead to the discovery of new anticancer drugs. Throughout this chapter, an overview of drug repositioning for anticancer applications, with a specific emphasis on activity-based drug repositioning of non-cancer medicines is provided. Several effective case studies of drug repurposi作者: acclimate 時(shí)間: 2025-3-27 07:22 作者: NATAL 時(shí)間: 2025-3-27 11:16 作者: Substitution 時(shí)間: 2025-3-27 13:49
Violence and Visibility in Modern Historye imatinib, saracatinib, and homoharringtonine, which have been studied for other coronaviruses in the past. Furthermore, current anticancer drugs like carmofur, carfilzomib, zotatifin, plitidepsin, and toremifene have gained interesting outcomes with respect to SARS-CoV-2. It is well recognized tha作者: Melatonin 時(shí)間: 2025-3-27 21:33
Drug Repurposing for Emerging Infectious Diseases and Cancer作者: mediocrity 時(shí)間: 2025-3-28 01:51
Drug Repurposing for Emerging Infectious Diseases and Cancer978-981-19-5399-6作者: Arrhythmia 時(shí)間: 2025-3-28 03:54
Drug Repurposing: An Advance Way to Traditional Drug Discovery,approaches are already developed to increase the speed and ease of the repurposing process. With the advancement of technologies such as proteomics, genomics, transcriptomics, metabolomics and the availability of massive databases resources such as drug omics data, disease omics data and so on, ther作者: Iatrogenic 時(shí)間: 2025-3-28 07:25
Pharmacovigilance-Based Drug Repurposing,drugs which are already approved for any condition. Inverse signaling approach takes cues from data mining approaches, applied to pharmacovigilance databases. Currently, this approach is being tried to evaluate existing compounds for Raynaud’s phenomenon, COVID-19, Alzheimer’ disease, etc. In this c作者: colony 時(shí)間: 2025-3-28 12:11
Drug Repurposing Opportunities in Cancer,t chapter, we have discussed the importance of repurposed therapeutics, barriers in DR, and computational approaches in DR..The opportunities of repurposing small-molecules non-oncology therapeutics and phytochemicals against assorted cancers are also discussed. Furthermore, repurposed cargos in cli作者: 道學(xué)氣 時(shí)間: 2025-3-28 14:41
,Targeted Therapies Used in the Treatment of Non–Small-Cell Lung Cancer: An Overview,ects. The use of these targeted therapies has managed to provide clinical benefits to selected patients. But complete cure and survival rates for NSCLC remain elusive, especially in metastatic disease. Hence, there is a?continuous search for targeted drugs and combination therapies to enhance the cl作者: Thyroiditis 時(shí)間: 2025-3-28 20:03
Drug Repurposing in Cancer,nd associated investigations of drug repurposing over the previous decade. Some of these medications successfully regulate at least one characteristic of cancer, whereas the others have a broad anticancer activity by regulating several targets through different signaling pathways, which is often bro作者: 松緊帶 時(shí)間: 2025-3-29 02:48
Drug Repurposing for, ENT and Head and Neck, Infectious and Oncologic Diseases: Current Practices antifungal therapies. There is an urgent need to combat these emerging pathogens and investigate the molecular mechanisms underlying their potentiated virulence traits to identify potential therapeutic targets susceptible to anti-fungal compounds. The drug development process for IFIs remains largely作者: 細(xì)胞 時(shí)間: 2025-3-29 06:51 作者: 不自然 時(shí)間: 2025-3-29 10:04 作者: Adornment 時(shí)間: 2025-3-29 11:31 作者: 細(xì)查 時(shí)間: 2025-3-29 18:31 作者: Range-Of-Motion 時(shí)間: 2025-3-29 21:52
Repurposing Drugs for Viruses and Cancer: A Novel Drug Repositioning Strategy for COVID-19,e imatinib, saracatinib, and homoharringtonine, which have been studied for other coronaviruses in the past. Furthermore, current anticancer drugs like carmofur, carfilzomib, zotatifin, plitidepsin, and toremifene have gained interesting outcomes with respect to SARS-CoV-2. It is well recognized tha作者: 預(yù)定 時(shí)間: 2025-3-30 02:02
Drug Repurposing: An Advance Way to Traditional Drug Discovery,s such as drug repurposing are required to develop therapeutics to treat both common and rare disorders. Drug repurposing is a potential approach in drug discovery for identifying new therapeutic applications for existing medications that are distinct from the original medical indication. Identifica作者: GENRE 時(shí)間: 2025-3-30 04:50 作者: 形容詞 時(shí)間: 2025-3-30 12:02 作者: Trypsin 時(shí)間: 2025-3-30 14:06 作者: 等待 時(shí)間: 2025-3-30 20:11 作者: Abrade 時(shí)間: 2025-3-30 23:36 作者: Crohns-disease 時(shí)間: 2025-3-31 01:15 作者: 割公牛膨脹 時(shí)間: 2025-3-31 07:36 作者: muscle-fibers 時(shí)間: 2025-3-31 11:27
Targeting the Ubiquitin Machinery for Cancer Therapeutics,ssential components of UPS (Ubiquitinating enzymes-E1, E2, E3, deubiquitinases, and proteasome machinery) is complex and multifaceted, and their dysregulation has been implicated in several diseases including cancer. Increasing number of studies has established UPS as a cancer therapeutic target. In作者: 人類(lèi)學(xué)家 時(shí)間: 2025-3-31 14:10 作者: Perceive 時(shí)間: 2025-3-31 20:07 作者: Restenosis 時(shí)間: 2025-3-31 23:26 作者: pericardium 時(shí)間: 2025-4-1 04:14
Repurposing of Immunomodulators for the Treatment of Cancer with QSAR Approaches,r cancer treatments. Over the last decades, the immunomodulators agent increased their interest as the therapeutic agents against various conditions, including cancer diseases. Furthermore, they also provide inexpensive and less toxic extracts from the plants compared to other chemical poisonous che作者: Morose 時(shí)間: 2025-4-1 08:17 作者: Rejuvenate 時(shí)間: 2025-4-1 14:09 作者: 以煙熏消毒 時(shí)間: 2025-4-1 17:38
Repurposing of Drugs for the Treatment of Microbial Diseases,overy and development of new antimicrobial agents. Traditional drug discovery and development involves several stages for the discovery of a new drug and to obtain marketing approval. Drug repurposing also referred to as drug repositioning has been influential in identifying new therapeutic uses for作者: 會(huì)犯錯(cuò)誤 時(shí)間: 2025-4-1 20:02
